Platelet-rich plasma (PRP) and tendon healing: comparison between fresh and frozen-thawed PRP

References

• Kaux JF, Drion P, Croisier JL, Crielaard JM. Tendinopathies and platelet-rich plasma (PRP): from pre-clinical experiments to therapeutic use. J Stem Cells Regen Med 2015 May 30;11(1):7–17.
   PubMed Web of Science ®Google Scholar
• Maffulli N, Del Buono A. Platelet plasma rich products in musculoskeletal medicine: any evidence? Surgeon 2012 Jun;10(3):148–150. doi:10.1016/j.surge.2011.03.004
   PubMed Web of Science ®Google Scholar
• Zhang JY, Fabricant PD, Ishmael CR, Wang JC, Petrigliano FA, Jones KJ. Utilization of platelet-rich plasma for musculoskeletal injuries: an analysis of current treatment trends in the United States. Orthop J Sports Med 2016 Dec 21;4(12):2325967116676241.
   Web of Science ®Google Scholar
• Campbell KA, Saltzman BM, Mascarenhas R, Khair MM, Verma NN, Bach BR Jr, Cole BJ. Does intra-articular platelet-rich plasma injection provide clinically superior outcomes compared with other therapies in the treatment of knee osteoarthritis? A systematic review of overlapping meta-analyses. Arthroscopy 2015 Nov;31(11):2213–2221. doi:10.1016/j.arthro.2015.03.041
   PubMed Web of Science ®Google Scholar
• Milants C, Bruyère O, Kaux JF. Responders to platelet-rich plasma in osteoarthritis: a technical analysis. Biomed Res Int 2017;2017:7538604. doi:10.1155/2017/7538604
   PubMedGoogle Scholar
• Bruyère O, Cooper C, Cutolo M, Reginster JY. International endorsement of the ESCEO algorithm for management of knee osteoarthritis in clinical practice. Semin Arthritis Rheum 2017 Oct;47(2):e10. doi:10.1016/j.semarthrit.2017.07.002
   PubMedGoogle Scholar
• Reginster JY, Reiter-Niesert S, Bruyère O, Berenbaum F, Brandi ML, Branco J, Devogelaer JP, Herrero-Beaumont G, Kanis J, Maggi S, et al. Recommendations for an update of the 2010 European regulatory guideline on clinical investigation of medicinal products used in the treatment of osteoarthritis and reflections about related clinically relevant outcomes: expert consensus statement. Osteoarthritis Cartilage 2015 Dec;23(12):2086–2093. doi:10.1016/j.joca.2015.07.001
   Google Scholar
• Smets F, Croisier JL, Forthomme B, Crielaard JM, Kaux JF. Applications cliniques du plasma riche en plaquettes (PRP) dans les lésions tendineuses: revue de la literature. Science & Sport 2012;27(2):141–153. doi:10.1016/j.scispo.2011.12.007
   Google Scholar
• Kaux JF, Bouvard M, Lecut C, Oury C, Gothot A, Sanchez M, Crielaard JM. Reflections about the optimisation of the treatment of tendinopathies with PRP. Muscles Ligaments Tendons J 2015 Mar 27;5(1):1–4.
   PubMedGoogle Scholar
• Kaux JF, Emonds-Alt T. The use of platelet-rich plasma to treat chronic tendinopathies: a technical analysis. Platelets 2017 Jul 31;1–15. doi:10.1080/09537104.2017.1336211 [Epub ahead of print].
   PubMed Web of Science ®Google Scholar
• Anitua E,de la Fuente M, Riestra A, Merayo-Lloves J, Muruzábal F, Orive G. Preservation of biological activity of plasma and platelet-derived eye drops after their different time and temperature conditions of storage. Cornea 2015 Sep;34(9):1144–1148. doi:10.1097/ICO.0000000000000489
   Web of Science ®Google Scholar
• Strandberg G, Sellberg F, Sommar P, Ronaghi M, Lubenow N, Knutson F, Berglund D. Standardizing the freeze-thaw preparation of growth factors from platelet lysate. Transfusion 2017 Apr;57(4):1058–1065. doi:10.1111/trf.13998
   PubMed Web of Science ®Google Scholar
• Roffi A, Filardo G, Assirelli E, Cavallo C, Cenacchi A, Facchini A, Grigolo B, Kon E, Mariani E, Pratelli L, et al. Does platelet-rich plasma freeze-thawing influence growth factor release and their effects on chondrocytes and synoviocytes? Biomed Res Int 2014;2014:692913. doi:10.1155/2014/692913
   PubMedGoogle Scholar
• Kaux JF, Drion PV, Colige A, Pascon F, Libertiaux V, Hoffmann A, Janssen L, Heyers A, Nusgens BV, Le Goff C, et al.  Effects of platelet-rich plasma (PRP) on the healing of Achilles tendons of rats. Wound Repair Regen 2012 Sep-Oct;20(5):748–756. doi:10.1111/j.1524-475X.2012.00826.x
   PubMed Web of Science ®Google Scholar
• Kaux JF, Janssen L, Drion P, Nusgens B, Libertiaux V, Pascon F, Heyeres A, Hoffmann A, Lambert C, Le Goff C, et al. Vascular endothelial growth factor-111 (VEGF-111) and tendon healing: preliminary results in a rat model of tendon injury. Muscles Ligaments Tendons J 2014 May 8;4(1):24–28.
   PubMedGoogle Scholar
• Greimers L, Drion PV, Colige A, Libertiaux V, Denoël V, Lecut C, Gothot A, Kaux JF. Effects of allogeneic Platelet-Rich Plasma (PRP) on the healing process of sectioned achilles tendons of rats: a methodological description. J Vis Exp. 2018 Mar 19;(133).
   Google Scholar
• Kaux JF, Drion P, Libertiaux V, Colige A, Hoffmann A, Nusgens B, Besançon B, Forthomme B, Le Goff C, Franzen R, et al. Eccentric training improves tendon biomechanical properties: a rat model. J Orthop Res 2013 Jan;31(1):119–124. doi:10.1002/jor.22202
   PubMed Web of Science ®Google Scholar
• Kaux JF, Libertiaux V, Leprince P, Fillet M, Denoel V, Wyss C, Lecut C, Gothot A, Le Goff C, Croisier JL, et al. Eccentric training for tendon healing after acute lesion: a rat model. Am J Sports Med 2017 May;45(6):1440–1446. doi:10.1177/0363546517689872
   PubMed Web of Science ®Google Scholar
• Virchenko O, Aspenberg P. How can one platelet injection after tendon injury lead to a stronger tendon after 4 weeks? Interplay between early regeneration and mechanical stimulation. Acta Orthop 2006 Oct;77(5):806–812. doi:10.1080/17453670610013033
   PubMed Web of Science ®Google Scholar
• Wieloch P, Buchmann G, Roth W, Rickert M. A cryo-jaw designed for in vitro tensile testing of the healing Achilles tendons in rats. J Biomech 2004 Nov;37(11):1719–1722. doi:10.1016/j.jbiomech.2004.01.027
   PubMed Web of Science ®Google Scholar
• Alio JL, Rodriguez AE, Ferreira-Oliveira R, Wróbel-Dudzińska D, Abdelghany AA. Treatment of dry eye disease with autologous platelet-rich plasma: a prospective, interventional, non-randomized study. Ophthalmol Ther 2017 Dec;6(2):285–293. doi:10.1007/s40123-017-0100-z
   PubMed Web of Science ®Google Scholar
• Kaux JF, Croisier JL, Bruyere O, Rodriguez De La Cruz C, Forthomme B, Brabant G, Lapraille S, Lonneux V, Noel D, Le Goff C, et al. One injection of platelet-rich plasma associated to a submaximal eccentric protocol to treat chronic jumper’s knee. J Sports Med Phys Fitness 2015 Sep;55(9):953–961.
   PubMed Web of Science ®Google Scholar
• Kaux JF, Bruyere O, Croisier JL, Forthomme B, Le Goff C, Crielaard JM. One-year follow-up of platelet-rich plasma infiltration to treat chronic proximal patellar tendinopathies. Acta Orthop Belg 2015 Jun;81(2):251–256.
   PubMed Web of Science ®Google Scholar
• Garg S, Manchanda S. Platelet-rich plasma-an ‘Elixir’ for treatment of alopecia: personal experience on 117 patients with review of literature. Stem Cell Investig 2017 Jul;18(4):64. doi:10.21037/sci.2017.06.07
   Google Scholar
• Kaux JF, Croisier JL, Léonard P, Le Goff C, Crielaard JM. Exuberant inflammatory reaction as a side effect of platelet-rich plasma injection in treating one case of tendinopathy. Clin J Sport Med 2014 Mar;24(2):150–152. doi:10.1097/JSM.0b013e31829aa410
   PubMed Web of Science ®Google Scholar
• Kaux JF, Degrave N, Crielaard JM. Platelet-rich plasma: traitement des tendinopathies chroniques? Revue de la literature. Journal De Traumatologie Du Sport 2007;24(2):99–102. doi:10.1016/j.jts.2007.03.002
   Google Scholar
• Venter NG, Marques RG, Santos JS, Monte-Alto-Costa A. Use of platelet-rich plasma in deep second- and third-degree burns. Burns 2016 Jun;42(4):807–814. doi:10.1016/j.burns.2016.01.002
   PubMed Web of Science ®Google Scholar
• Kaux JF, Croisier JL, Forthomme B, Le Goff C, Buhler F, Savanier B, Delcour S, Gothot A, Crielaard JM. Using platelet-rich plasma to treat jumper’s knees: exploring the effect of a second closely-timed infiltration. J Sci Med Sport 2016 Mar;19(3):200–204. doi:10.1016/j.jsams.2015.03.006
   PubMed Web of Science ®Google Scholar
• Baik SY, Lim YA, Kang SJ, Ahn SH, Lee WG, Kim CH. Effects of platelet lysate preparations on the proliferation of HaCaT cells. Ann Lab Med 2014 Jan;34(1):43–50. doi:10.3343/alm.2014.34.1.43
   PubMed Web of Science ®Google Scholar
• Cowan DH, Graham J. Stimulation of human tumor colony formation by platelet lysate. J Lab Clin Med 1983 Dec;102(6):973–986.
   PubMed Web of Science ®Google Scholar
• Marck RE, Gardien KLM, Vlig M, Breederveld RS, Middelkoop E. Growth factor quantification of platelet-rich plasma in burn patients compared to matched healthy volunteers. Int J Mol Sci 2019;20:288. doi:10.3390/ijms20020288
   Web of Science ®Google Scholar
• Fekete N, Gadelorge M, Fürst D, Maurer C, Dausend J, Fleury-Cappellesso S, Mailänder V, Lotfi R, Ignatius A, Sensebé L. Platelet lysate from whole blood-derived pooled platelet concentrates and apheresis-derived platelet concentrates for the isolation and expansion of human bone marrow mesenchymal stromal cells: production process, content and identifi cation of active components. Cytotherapy 2012;14:540–554.
   PubMed Web of Science ®Google Scholar
• Roffi A, Filardo G, Assirelli E, Cavallo C, Cenacchi A, Facchini A, Grigolo B, Kon E, Mariani E, Pratelli L, et al. Does platelet-rich plasma freeze-thawing influence growth factor release and their effects on chondrocytes and synoviocytes? Biomed Res Int 2014;Article ID 692913:10. doi:10.1155/2014/692913
   Google Scholar
• Strandberg G, Sellberg F, Sommar P, Ronaghi M, Lubenow N, Knutson F, Berglund D. Standardizing the freeze-thaw preparation of growth factors from platelet lysate. Transfusion 2017;57:1058–1065. doi:10.1111/trf.14228
   PubMed Web of Science ®Google Scholar
• van den Dolder J, Mooren R, Vloon AP, Stoelinga PJ, Jansen JA. Platelet-rich plasma: quantification of growth factor levels and the effect on growth and differentiation of rat bone marrow cells. Tissue Eng 2006 Nov;12(11):3067–3073. doi:10.1089/ten.2006.12.3067
   PubMedGoogle Scholar